Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.
Daniel C. Chung(Icahn School of Medicine at Mount Sinai), Andrew Arnold(University of Connecticut), Andrew L. Warshaw(Massachusetts General Hospital), Robert T. Jensen(Unknown), Scott Brown(Altair Engineering (United States)), Loyal G. Tillotson, Fiona Graeme‐Cook
PubMed
August 15, 1998
Cited by 98
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k